RAR and RXR modulation in cancer and metabolic disease.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 10, p. 793, doi. 10.1038/nrd2397
- By:
- Publication type:
- Article
Works matching IS 14741776 AND DT 2007 AND VI 6 AND IP 10
Results: 20
1
2
Design of selective nuclear receptor modulators: RAR and RXR as a case study.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 10, p. 811, doi. 10.1038/nrd2398
- By:
- Publication type:
- Article
3
Non-insulin therapies for type 2 diabetes.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 10, p. 777, doi. 10.1038/nrd2420
- By:
- Publication type:
- Article
4
Aliskiren.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 10, p. 779, doi. 10.1038/nrd2421
- By:
- Publication type:
- Article
5
Cardiovascular disease: Reducing the pressure.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 10, p. 782, doi. 10.1038/nrd2426
- By:
- Publication type:
- Article
6
Flying under the radar: the new wave of BCR–ABL inhibitors.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 10, p. 834, doi. 10.1038/nrd2324
- By:
- Publication type:
- Article
7
Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 10, p. 821, doi. 10.1038/nrd2359
- By:
- Publication type:
- Article
8
Growth of the Asian health-care market: global implications for the pharmaceutical industry.
- Published in:
- 2007
- By:
- Publication type:
- review
9
Drug metabolism: Production line for hepatocytes.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 10, p. 781, doi. 10.1038/nrd2427
- By:
- Publication type:
- Article
10
RNA interference: Targeted knockdown.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 10, p. 784, doi. 10.1038/nrd2428
- By:
- Publication type:
- Article
11
Anticancer drugs: Forecasting drug responses.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 10, p. 782, doi. 10.1038/nrd2429
- By:
- Publication type:
- Article
12
Cytokine hormones: Designed to linger.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 10, p. 783, doi. 10.1038/nrd2430
- By:
- Publication type:
- Article
13
News & Analysis.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 10, p. 774, doi. 10.1038/nrd2436
- Publication type:
- Article
14
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 10, p. 765, doi. 10.1038/nrd2439
- Publication type:
- Article
15
In Brief.
- Published in:
- 2007
- Publication type:
- Abstract
16
Steps on the road to personalized medicine.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 10, p. 770, doi. 10.1038/nrd2434
- By:
- Publication type:
- Article
17
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 10, p. 772, doi. 10.1038/nrd2435
- Publication type:
- Article
18
Tools and technologies.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 10, p. 849, doi. 10.1038/nrd2432
- By:
- Publication type:
- Article
19
Resolving the access dilemma.
- Published in:
- Nature Reviews Drug Discovery, 2007, v. 6, n. 10, p. 769, doi. 10.1038/nrd2433
- By:
- Publication type:
- Article
20
Dealing with a data deficit.
- Published in:
- 2007
- Publication type:
- Editorial